Global Biochips Industry

  • March 2012
  • -
  • Global Industry Analysts
  • -
  • 630 pages

This report analyzes the worldwide markets for Biochips in US$ Million by the following Product Segments: DNA Chips, Protein Chips, and Lab Chips. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Middle East, and Latin America. The report profiles 77 companies including many key and niche players such as Affymetrix Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Caliper Life Sciences, Inc., Cepheid Inc., Fluidigm Corporation, GE Healthcare Ltd., Illumina, Inc., Life Technologies Corporation, Ocimum Biosolutions Ltd., Takara Bio, Inc., Clontech Laboratories, Inc., and Zyomyx, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table Of Contents




I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-3
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
A. DNA Chips I-3
B. Protein Chips I-4
C. Lab Chips I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
A Primer II-1
Recession Dries Up Funds for Biotech Firms II-1
Promising Biochips Promote Biological Research II-2
Key Forces Driving the Industry II-3
DNA Chips Lead the Application Front II-3
Protein Biochips - Set for Robust Expansion II-3
Lab-on-a-Chips: Fusion of Nanotechnology and Genetic Engineering II-4
Industry Challenges II-4
Standardization: A Key Challenge II-4
Price Dearness Pauses Biochips Growth II-5

2. MARKET DYNAMICS II-6
Current Approaches to Biochips II-6
The Business of Biochips II-6
Technological Differentiation in Demand II-7
Focus on Highly Intelligent Diagnostic Systems II-7
Scalability and Pricing - Focus Areas II-7
Biochips: Expanding Role in Diagnostic Medicine II-8
Advancements in Biochip Technology II-8
Biochip Technology Boosts Personalised Medicine II-9
Biochip Technology Spreads beyond Pharma Industry II-9
Proteomics “Chip” into Biochip Technology II-10
Towards Increasing Minaturization II-10
Technological Trends II-10
Sensitivity II-10
Microfabrication II-10
Density II-11
Integrated Chips II-11
Patent Trends II-11
Table 1: Number of Lab-on-a-Chip Patents (includes
corresponding Graph/Chart) II-11

Table 2: % of Lab-on-a-Chip Patent Documents by
Country/Authority of Origin (January 2008 - April 2009)
(includes corresponding Graph/Chart) II-12

Table 3: Number of Lab-on-a-Chip Documents by Patent
Assignees (January 2008 - April 2009) (includes
corresponding Graph/Chart) II-12
Patent Applications II-13

3. COMPETITION II-14
Industry Structure II-14
Major Participants II-14
Affymetrix: A Major Market Player II-14
Growing Partnerships between Pharma and Biotech Companies II-14
Tech Giants Join the Biochip Fray II-15

4. PRODUCT OVERVIEW II-17
Biochips - Complex Blend of Biochemistry and Electronics II-17
Historical Perspective II-17
Lab-on-a-chip: An Enabled Technology II-19
Utility II-19
Evolution and Segmentation II-19
Differing Perspectives II-19
Classification of Biochips II-20
Need for Biochips II-21
Manufacturing Systems Used in Biochip Manufacture II-21
Working of a Biochip II-22
DNA Transcription and Translation Through A Biochip II-22
A Functional Model II-22
Cocktail of Disparate Technically Specialized Applications II-23
Biochips: By-product of Multi-disciplinary Sciences II-23
Nanotechnology II-23
BioMEMS II-23
Microfluidics II-24
Micro Total Analysis System II-24

5. BIOCHIP AND MICROARRAY CONSTRUCTION II-26
Chip Architecture II-26
Essence of a Biochip II-26
Concept of a Microarray II-26
Microarray Modules II-26
High Degree of Automation Spurs Biochips Use II-27
Microfabrication Technology in Biochips made from Polymer and
Plastics II-27
Micro-optics in Biochips II-28
Liquid Handling Through Micro-Dispensers II-28
Capillary Electrophoresis and Electrochemical Detectors II-28
Other Technologies II-28
Management of Bio-information II-28
Scanning II-29
Microarray Database Management II-29
Classification of DNA Chips II-29
General Description of Spotted cDNA Microarrays II-29
Spotted DNA Arrays II-30
Spotted cDNA Versus Spotted Oligonucleotide Arrays II-30
Limitations of Conventional cDNA Microarrays II-30
Protein Biochips II-31
General Applications of Protein Biochips II-31
Challenges in the Design of a Protein Biochip II-32
Limitations of Protein Chip Technology II-32
Concluding Remarks for Protein Biochips II-33

6. APPLICATIONS OF BIOCHIPS II-34
Biochip Uses II-35
Pharmaceutical Investigation II-35
Medical Diagnostics II-35
Advantages of Biosensor Chip Technology II-36
Forensics II-36
Transplantation Screening II-36
Identity Testing II-36
Water and Environmental Testing II-37
Food Industry II-37

7. PRODUCT INNOVATIONS/INTRODUCTIONS II-38
Randox Launches Evidence Evolution Analyzer II-38
South Korea Develops Instant Microfluidic Biochip II-38
Fluidigm Introduces Reusable FR48.48 Dynamic Arrayâ„¢ IFC II-38
Cellix Introduces Vena4Yâ„¢ and Vena4Y2â„¢ Biochips II-38
Agilent Technologies Unveils Workflow HPLC-Chip II-39
Febit Holding Introduces First Human Cancer Biochip II-39
Blue4Green Rolls Out Lab-on-a-chip Solution II-40
Randox Laboratories Unveils Biochip Arrays II-40
Randox Laboratories Introduces Evidence Investigator II-40
Randox Unveils Innovative DoA Biochips for Rapid Drug Screening II-41
Randox Launches Revolutionary Biochip Analyser for Multiple
Cardiac Testing II-41
Febit Unveils Biochip for DNA/RNA Detection and Enrichment on
Mouse Genome II-42
Veredus Laboratories Launches Portable Test Kit for H1N1 Flu II-42
Randox Develops Multi Marker Cardiac Biochip Array for MI
Diagnosis II-42
VigeneTech and CapitalBio Launch Completely Integrated
Microarray Solution Platform II-43

8. PRODUCT INNOVATIONS/INTRODUCTIONS - A HISTORIC PERSPECTIVE BUILDER II-44
Randox Introduces New Biochip Array for CAMs Testing II-44
Cellix Announces Global Launch of VenaEC Biochip II-44
Decision Biomarkers Rolls Out AVANTRAâ„¢ Biomarker Workstation
System II-44
Osaka Develops Biocompatible Monomers for Biochips II-45
Iris BioTechnologies Launches New Nano-Biochip II-45
Affymetrix Introduces Complete Cytogenetic Solution II-45
Agilent Unveils 244K CGH Micro-Array II-46
Randox Unveils World’s First Protein Biochip II-46
Randox Introduces Thyroid Array Biochip II-46
Sigma Launches ChIP Kit II-46
Randox Develops Biochip for Synthetic Steroids II-47
US and Czech Scientists to Develop Biochips for Detecting Cancer II-47
Manchester University Researchers Develop New Protein Chips
Manufacturing Procedure II-47
febit Introduces New Geniom Biochip II-48
Agilent Introduces Additions to the HPLC-Chip Line for Proteomics II-49
Progenika Develops BLOODchip II-49
Roche Introduces Gene Expression Services and Arrays II-49
Stratos Biosystems Develops New EC-Affinity Biochips II-50
Affymetrix Unveils Affymetrix GeneChip Command Console Software II-50
Affymetrix Introduces GeneChip Mouse and Rat Gene 1.0 ST Arrays II-50
Affymetrix Unveils Genome-Wide Human SNP Array 6.0 II-51
Caliper Life Sciences Launches High Throughput RNA Assay II-51
Applied Biosystems Unveils DNA Tools II-52
febit Launches Geniom RT Analyzer II-52
Austrian Research Center Develops New Biochip Surface II-52
Researchers Develop Biochips to Eliminate Animal Testing II-53
Progenika Biopharma Launches IBD DNA II-53
Bioident Develops New Lab-on-a-Chip Nanotiter Plate Prototype II-53
Ilochip and University of Denmark Develop a Biochip for Faster
Bird Flu Detection II-54
CombiMatrix Develops a Biochip for Leukemia Analysis II-54
Affymetrix Launches New Tiling Arrays for Mapping Whole-Genome
Transcript II-54
Roche Plans to Launch AmpliChip in Japan II-54
Caliper Life Sciences Unveils Desktop Profiler II-55
Massachusetts Institute of Technology Develops Portable Lab on
a Chip II-55
Optical Device to Develop Lab-on-a-Chip II-55
Agilent Launches Five New HPLC Chips II-56
Protagen AG Launches New Protein Biochips II-56
Fluidigm Releases the 8.96 TOPAZ Screening Chip II-56
Affymetrix Releases Chip-on-Chip Array II-56
DNA Chip Research Launches High Sensitivity DNA Chip II-56
DNA Chip Research and HitachiSoft Unveils AceGene II-56

9. RECENT INDUSTRY ACTIVITY II-57
PerkinElmer Acquires Caliper Life Sciences II-57
Philips and bioMerieux to Produce Biochips for Cardiovascular
Assays II-57
Roche Diagnostics and CapitalBio to Sign MOU II-57
SVTC Partners with TSMC to Commercialize New Technologies II-58
HORIBA Jobin Yvon Takes Over GenOptics II-58
GWC Technologies to Receive $100,000 Federal Grant II-58
febit to Receive Funds for Biomarker Project II-59
Researchers Assess TB-Biochip MDR Test System II-59
IBM to Use DNA Chip for Developing Personalized Medicine II-59

10. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-60
Invitrogen and Applied Biosystems Merge to Form Life
Technologies Corporation II-60
China Medical Technologies Signs Agreement with Molecular
Diagnostics Technologies II-60
DNA Chip Acquires HuBit’s Gene Analysis Business II-60
Affymetrix Acquires USB II-61
Roche NimbleGen Forms Alliance with BioDiscovery to Provide
CGH Solutions II-61
Illumina Announces Partnership with Genpathway for ChIP
Sequencing Services II-61
Jiangsu and IMDi Diagnosis to Establish Joint Venture II-62
Plexera Biosciences Enters into an Option Deal with Auguron II-62
Affymetrix and Avesthagen Enter into an Agreement II-63
Roche NimbleGen and Affymetrix Announce Expansion of License
Agreement II-63
Proteomika and Auguron Biosciences Ink Option Agreement II-63
Gentel Biosciences and Eppendorf Enter into Global License
Agreement II-64
GATC Biotech Establishes New Subsidiary II-64
Procognia Spins off Sense Proteomic II-65
Johns Hopkins University Purchases MassARRAY System II-65
Yale University Purchases MassARRAY System II-65
Korea’s NIH Extends KARE Project with Affymetrix Technology II-65
febit Obtains US Patent for Hybselect, a Microfluidic
Extraction Method II-66
Atotech Enters into Research Collaboration with University of
Albany II-66
CapitalBio and Beijing National Engineering Research Center
Develop New Biochip Testing System II-66
Roche Takes Over NimbleGen II-67
GenTel BioSciences Acquires Protein Chip Platform Assets of GSK II-67
Advanced Liquid Logic Acquires Nanolytics II-68
Applied Microarrays Acquires Select GE Healthcare’s Assets II-68
Canon, Toshiba and Other Companies to Join Hands for Biochips II-69
BioChip Innovations Signs Research Collaboration Agreement
with IME II-69
Protagen Enters into a Partnership to Develop Antibodies II-69
Spanish Society of Rheumatology Enters into Collaboration with
Progenika II-70
Affymetrix and Partners Healthcare Extend Collaboration II-70
Agencourt, NuGEN and Affymetrix Clinical Services Collaborate II-70
Affymetrix Inks Licensing Agreement with Empire Genomics II-71
Caliper Enters into a Licensing Agreement with Monogram
Biosciences II-71
Affymetrix and IPSOGEN Sign Agreement II-72
bioMerieux and NuGEN Enter into Supply and Cross-License
Agreement II-72
VWR and CapitalBio Enter into a Distribution Agreement II-73
C3B Bags Contract from Department of Defense to Develop an
Implantable Biochip II-73
UCL Subsidiary and Roche Diagnostics Ink Licensing Deal II-73
Affymetrix Establishes the European Cytogenetic Research
Initiative II-74
Fluidigm Establishes New Development Center II-74
Daiichi Pure Chemicals Applies for Approval to Market DNA
Micro-array II-74
GE Healthcare Snaps Up Biacore II-75
Bio-Rad Acquires Ciphergen’s Life Science Research Business II-75
Sysmex to Form Partnership with Affymetrix II-75
Daiichi, Toshiba Hokuto and Toshiba Join Hands II-75
Affymetrix Collaborates with Zhejiang California Nanosystem
Institute II-76
Merck Sharp and Dohme and Shanghai Biochip Enter into Co-
operation Agreement II-76
Toshiba Signs Licensing Agreement with Antara BioSciences II-77
MUSC Signs LOI with Lumera II-77
AVIVA Inks Agreement with Japan’s Cosmo Bio II-77
Lumera Signs Collaborative Agreement with Harvard Medical School II-77
Whatman Receives CE Mark for CombiChip II-78
IDIBAPS Led Project Receives Approval from European Union II-78
Toray to Establish DNA Chip Business II-79
Protagen Forays into the US Market II-79
Biacore Expands Operations into Chinese Market II-79
Nisshinbo to Replace Glass with Resin in DNA Production II-79

11. FOCUS ON SELECT GLOBAL PLAYERS II-80
Affymetrix Inc (US) II-80
Agilent Technologies, Inc. (US) II-80
Bio-Rad Laboratories, Inc. (US) II-81
Caliper Life Sciences, Inc. (US) II-81
Cepheid Inc. (US) II-81
Fluidigm Corporation (US) II-82
GE Healthcare Ltd. (UK) II-82
Illumina, Inc. (US) II-82
Life Technologies Corporation (US) II-83
Ocimum Biosolutions Ltd. (India) II-83
Takara Bio, Inc. (Japan) II-84
Clontech Laboratories, Inc. (US) II-84
Zyomyx, Inc. (US) II-84

12. GLOBAL MARKET PERSPECTIVE II-85
Table 4: World Recent Past, Current and Future Analysis for
Biochips by Geographic Region - US, Canada, Japan, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-85

Table 5: World Historic Review for Biochips by Geographic
Region - US, Canada, Japan, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-86

Table 6: World 15-Year Perspective for Biochips by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, and Rest of World Markets for Years 2003, 2011
and 2017 (includes corresponding Graph/Chart) II-87

Table 7: World Recent Past, Current and Future Analysis for DNA
Chips by Geographic Region - US, Canada, Japan, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-88

Table 8: World Historic Review for DNA Chips by Geographic
Region - US, Canada, Japan, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-89

Table 9: World 15-Year Perspective for DNA Chips by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, and Rest of World Markets for Years 2003,
2011 and 2017 (includes corresponding Graph/Chart) II-90

Table 10: World Recent Past, Current and Future Analysis for
Protein Chips by Geographic Region - US, Canada, Japan,
Europe, and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) II-91

Table 11: World Historic Review for Protein Chips by
Geographic Region - US, Canada, Japan, Europe, and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-92

Table 12: World 15-Year Perspective for Protein Chips by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, and Rest of World Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) II-93

Table 13: World Recent Past, Current and Future Analysis for Lab
Chips by Geographic Region - US, Canada, Japan, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-94

Table 14: World Historic Review for Lab Chips by Geographic
Region - US, Canada, Japan, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-95

Table 15: World 15-Year Perspective for Lab Chips by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, and Rest of World Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) II-96


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
An Insight into Biochip Products and Services Market III-1
Rapid Growth for Protein, Lab Biochips III-1
Robust Demand for Biochip Reagents and Consumables III-2
Growth Prospects for Biochip Instruments and Software III-2
Potential for Biochip Service Revenues III-2
Biochip Product and Service Demand Among Biotech Companies III-3
Biochip Products and Services Demand in Life Science
Research Applications III-3
Laboratory Chips Market III-4
Table 16: US Laboratory Chip Market by Application (2007 and
2015P): Percentage Share Breakdown of Revenues for Life
Science Research, Forensic Medicine, In Vitro Diagnostic
Testing, Drugs-of- Abuse Testing, Disease Management, and
Others (includes corresponding Graph/Chart) III-4
Competitive Landscape III-5
Table 17: Leading Players in the US Biochip Products and
Services Market (2007): Percentage Share Breakdown of
Revenues for Illumina, Affymetrix, Applied Biosystems,
GE/Amersham, Invitrogen, Bio-Rad, Caliper Life Science,
Cepheid, Agilent Techs, Beckman Coulter, and Others
(includes corresponding Graph/Chart) III-5
B.Market Analytics III-6
Table 18: US Recent Past, Current and Future Analysis for
Biochips by Product Segment - DNA Chips, Protein Chips and
Lab Chips Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-6

Table 19: US Historic Review for Biochips by Product Segment
- DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-7

Table 20: US 15-Year Perspective for Biochips by Product
Segment - Percentage Breakdown of Dollar Sales for DNA
Chips, Protein Chips and Lab Chips Markets for Years 2003,
2011 and 2017 (includes corresponding Graph/Chart) III-8

2. CANADA III-9
Market Analytics III-9
Table 21: Canadian Recent Past, Current and Future Analysis
for Biochips by Product Segment - DNA Chips, Protein Chips
and Lab Chips Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-9

Table 22: Canadian Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-10

Table 23: Canadian 15-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) III-11

3. JAPAN III-12
A.Market Analysis III-12
ICANâ„¢ Technology for Large-Scale Production of DNA Fragments III-12
B.Market Analytics III-13
Table 24: Japanese Recent Past, Current and Future Analysis
for Biochips by Product Segment - DNA Chips, Protein Chips
and Lab Chips Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-13

Table 25: Japanese Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-14

Table 26: Japanese 15-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) III-15

4. EUROPE III-16
A.Market Analysis III-16
Lab-on-chip Market in Europe III-16
European Advancements Shape Diagnostic Procedures III-17
B.Market Analytics III-17
Table 27: European Recent Past, Current and Future Analysis
for Biochips by Geographic Region - France, Germany, UK, and
Rest of Europe Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-17

Table 28: European Historic Review for Biochips by
Geographic Region - France, Germany, UK, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-18

Table 29: European 15-Year Perspective for Biochips by
Geographic Region - Percentage Breakdown of Dollar Sales for
France, Germany, UK, and Rest of Europe Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) III-19

Table 30: European Recent Past, Current and Future Analysis
for Biochips by Product Segment - DNA Chips, Protein Chips
and Lab Chips Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-20

Table 31: European Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-21

Table 32: European 15-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) III-22

4a. FRANCE III-23
Market Analytics III-23
Table 33: French Recent Past, Current and Future Analysis for
Biochips by Product Segment - DNA Chips, Protein Chips and
Lab Chips Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-23

Table 34: French Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-24

Table 35: French 15-Year Perspective for Biochips by Product
Segment - Percentage Breakdown of Dollar Sales for DNA
Chips, Protein Chips and Lab Chips Markets for Years 2003,
2011 and 2017 (includes corresponding Graph/Chart) III-25

4b. GERMANY III-26
A.Market Analysis III-26
Berlin, Brandenburg and Biochips III-26
B.Market Analytics III-27
Table 36: German Recent Past, Current and Future Analysis for
Biochips by Product Segment - DNA Chips, Protein Chips and
Lab Chips Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-27

Table 37: German Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-28

Table 38: German 15-Year Perspective for Biochips by Product
Segment - Percentage Breakdown of Dollar Sales for DNA
Chips, Protein Chips and Lab Chips Markets for Years 2003,
2011 and 2017 (includes corresponding Graph/Chart) III-29

4c. THE UNITED KINGDOM III-30
Market Analytics III-30
Table 39: UK Recent Past, Current and Future Analysis for
Biochips by Product Segments- DNA Chips, Protein Chips and
Lab Chips Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-30

Table 40: UK Historic Review for Biochips by Product Segment-
DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-31

Table 41: UK 15-Year Perspective for Biochips by Product
Segment - Percentage Breakdown of Dollar Sales for DNA
Chips, Protein Chips and Lab Chips Markets for Years 2003,
2011 and 2017 (includes corresponding Graph/Chart) III-32

4d. REST OF EUROPE III-33
Market Analysis III-33
Table 42: Rest of Europe Recent Past, Current and Future
Analysis for Biochips by Product Segment - DNA Chips,
Protein Chips and Lab Chips Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) III-33

Table 43: Rest of Europe Historic Review for Biochips by
Product Segment - DNA Chips, Protein Chips and Lab Chips
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-34

Table 44: Rest of Europe 15-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) III-35

5. REST OF WORLD III-36
A.Market Analysis III-36
China III-36
Basic Environment and Commercial Development III-36
Biochip Research Institutes III-37
Taiwan III-37
Taiwan Pursues Promise of Biochip Sector III-37
International Advantage Sought III-37
B.Market Analytics III-38
Table 45: Rest of World Recent Past, Current and Future
Analysis for Biochips by Product Segment - DNA Chips,
Protein Chips and Lab Chips Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) III-38

Table 46: Rest of World Historic Review for Biochips by
Product Segment - DNA Chips, Protein Chips and Lab Chips
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-39

Table 47: Rest of World 15-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) III-40


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 77 (including Divisions/Subsidiaries - 87)

------------------------------------------
Region/Country Players
------------------------------------------
The United States 40
Japan 14
Europe 25
France 4
Germany 8
The United Kingdom 4
Spain 1
Rest of Europe 8
Asia-Pacific (Excluding Japan) 8
------------------------------------------

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Next-generation Sequencing Trends

Global Next-generation Sequencing Trends

  • $ 12 500
  • Industry report
  • September 2014
  • by Frost & Sullivan

An End-user Perspective The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house ...

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research report discusses market growth, size and opportunities with respect to applications, geographic region and technologies. Forecast trends and revenue are given through 2019. Major players, ...

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research report provides an overview of the current state of the microRNA (miRNA) market, focusing mainly on continuing research endeavors, newly emerging sophisticated tools, reagents, techniques, ...

Global Bioinformatics Industry

July 2014 $ 4 950

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.